OptiNose Statistics
Total Valuation
OptiNose has a market cap or net worth of $63.36 million. The enterprise value is $109.04 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OptiNose has 150.83 million shares outstanding. The number of shares has increased by 26.91% in one year.
| Current Share Class | 150.83M |
| Shares Outstanding | 150.83M |
| Shares Change (YoY) | +26.91% |
| Shares Change (QoQ) | +15.71% |
| Owned by Insiders (%) | 5.81% |
| Owned by Institutions (%) | 45.57% |
| Float | 92.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.76 |
| Forward PS | 0.68 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.79
| Current Ratio | 0.79 |
| Quick Ratio | 0.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.94 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -10.32% |
| Return on Capital (ROIC) | -16.99% |
| Revenue Per Employee | $573,273 |
| Profits Per Employee | -$235,970 |
| Employee Count | 132 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 0.77 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.47% in the last 52 weeks. The beta is -0.17, so OptiNose's price volatility has been lower than the market average.
| Beta (5Y) | -0.17 |
| 52-Week Price Change | -63.47% |
| 50-Day Moving Average | 0.59 |
| 200-Day Moving Average | 0.97 |
| Relative Strength Index (RSI) | 35.41 |
| Average Volume (20 Days) | 924,575 |
Short Selling Information
The latest short interest is 7.36 million, so 4.88% of the outstanding shares have been sold short.
| Short Interest | 7.36M |
| Short Previous Month | 9.07M |
| Short % of Shares Out | 4.88% |
| Short % of Float | 7.96% |
| Short Ratio (days to cover) | 6.05 |
Income Statement
In the last 12 months, OptiNose had revenue of $75.67 million and -$31.15 million in losses. Loss per share was -$0.29.
| Revenue | 75.67M |
| Gross Profit | 68.26M |
| Operating Income | -19.19M |
| Pretax Income | -40.91M |
| Net Income | -31.15M |
| EBITDA | -18.85M |
| EBIT | -19.19M |
| Loss Per Share | -$0.29 |
Full Income StatementBalance Sheet
The company has $82.50 million in cash and $128.18 million in debt, giving a net cash position of -$45.68 million or -$0.30 per share.
| Cash & Cash Equivalents | 82.50M |
| Total Debt | 128.18M |
| Net Cash | -45.68M |
| Net Cash Per Share | -$0.30 |
| Equity (Book Value) | -41.10M |
| Book Value Per Share | -0.27 |
| Working Capital | -34.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$39.64 million and capital expenditures -$145,000, giving a free cash flow of -$39.79 million.
| Operating Cash Flow | -39.64M |
| Capital Expenditures | -145,000 |
| Free Cash Flow | -39.79M |
| FCF Per Share | -$0.26 |
Full Cash Flow StatementMargins
Gross margin is 90.21%, with operating and profit margins of -25.35% and -41.16%.
| Gross Margin | 90.21% |
| Operating Margin | -25.35% |
| Pretax Margin | -41.16% |
| Profit Margin | -41.16% |
| EBITDA Margin | -24.91% |
| EBIT Margin | -25.35% |
| FCF Margin | n/a |
Dividends & Yields
OptiNose does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.91% |
| Shareholder Yield | -26.91% |
| Earnings Yield | -49.16% |
| FCF Yield | -62.79% |
Analyst Forecast
The average price target for OptiNose is $3.00, which is 614.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 614.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 29.87% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OptiNose has an Altman Z-Score of -7.63 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.63 |
| Piotroski F-Score | 2 |